Antiphospholipid antibodies in ocular arterial and venous occlusive disease

Ophthalmologica

Volumn 221, Issue 1, 2006, Pages 41-46

  Palmowski Wolfe, Anja M ^a   Denninger, Elke ^b   Geisel, Jürgen ^b   Pindur, Gerhard ^b   Ruprecht, Klaus W ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Anterior ischemic optic neuropathy; Anticardiolipin antibodies; Antiphospholipid antibodies; Lupus anticoagulants; Posterior ischemic optic neuropathy; Retinal artery occlusion; Retinal vein occlusion

Indexed keywords

ANTITHROMBOCYTIC AGENT; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHENPROCOUMON; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BRANCH RETINAL ARTERY OCCLUSION; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; MALE; RETINA ARTERY; RETINA VEIN; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRANSITIONAL BLINDNESS;

AGED; AMAUROSIS FUGAX; ANTIBODIES, ANTICARDIOLIPIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; OPTIC NEUROPATHY, ISCHEMIC; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION;

EID: 33845869554     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096521     Document Type: Article

References (23)

1. Durrani OM, Gordon C, Murray P: Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol 2002;47:215-238.
2. Galli M, Luciani D, Bertolini G, Barbui T: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-1832.
3. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G: Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998;7:15-22.
4. Wahl DG, De Maistre E, Guillemin F, Regnault V, Perret-Guillaume C, Lecompte T: Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus. QJM 1998;91:125-130.
5. Sammaritano LR: Significance of aPL IgG subclasses. Lupus 1996;5:436-439.
6. Ermakova NA, Alekberova ZS, Nasonov EL, Kosheleva NM, Reshetniak TM, Aleksandrova EN: Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases. Vestn Oftalmol 2002;118:29-32.
7. Glacet-Bernard A, Bayani N, Chretien P, Cochard C, Lelong F, Coscas G: Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol 1994;112:790-795.
8. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska RGM: Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions. Thromb Res 1996;83:183-188.
9. Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ, Teijeiro MA, Vidal P, Suarez-Leoz M, Rodriguez-Mahou M, Rodriguez-Huerta A, Fernandez-Cruz E, Cortes C: Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 1999;128:725-732.
10. Carbone J, Sanchez-Ramon S, Cobo-Soriano R, Seoane E, Aparicio MJ, Ruiz-Tiscar JL, Rodriguez-Mahou M, Rodriguez-Molina JJ, Sarmiento E, Cortes C, Fernandez-Cruz E: Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases. J Rheumatol 2001;28:2437-2441.
11. Scott JA, Arnold JJ, Currie JM, Broadfoot C, Davidson M, Kelly KF, Graham A, Kirkpatrick JN, Greaves M: No excess of factor V: Q506 genotype but high prevalence of anti-cardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients. Ophthalmologica 2001;215:217-221.
12. Abu El-Asrar AM, Abdel Gader AG, Al-Amro S, Al-Momen AK: Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998;95:133-143.
13. Simioni P, Prandoni P, Zanon E, Saracino MA, Scudeller A, Villalta S, Scarano L, Girolami B, Benedetti L, Girolami A: Deep venous thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996;76:187-189.
14. Bick RL: Antiphospholipid thrombosis syndromes. Clin Appl Thromb Hemost 2001;7:241-258.
15. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, Yassur I, Vidne O, Zivelin A, Gitel S, Davidson J, Ravid B, Seligsohn U: Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999;106:739-742.
16. Galetta SL, Plock GL, Kushner MJ, Wyszynski RE, Brucker AJ: Ocular thrombosis associated with antiphospholipid antibodies. Ann Ophthalmol 1991;23:207-212.
17. Leo-Kottler B, Klein R, Berg PA, Zrenner E: Ocular symptoms in association with antiphospholipid antibodies. Graefes Arch Clin Exp Ophthalmol 1998;236:658-668.
18. Tietjen GE, Levine SR, Brown E, Mascha E, Welch KM: Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological events. Arch Neurol 1994;50:833-836.
19. Kalogeropoulos CD, Spyrou P, Stefaniotou MI, Tsironi EE, Drosos AA, Psilas KG: Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study. Doc Ophthalmol 1998;95:109-120.
20. Bertram B, Haase G, Remky A, Reim M: Anticardiolipin antibodies in vascular occlusions of the eye. Ophthalmologe 1994;91:768-771.
21. Doig RG, O'Malley CJ, Dauer R, McGrath KM: An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable states. Am J Clin Pathol 1994;102:797-801.
22. Janssen M, den Heijer M, Cruysberg J, Wollersheim H, Bredie S: Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005;93:1021-1026.
23. Munoz-Rodriguez FJ, Font J, Cervera R, Reverter JC, Tassies D, Espinosa G, Lopez-Soto A, Carmona F, Balasch J, Ordinas A, Ingelmo M: Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999;29:182-190.